Stock RAPH RAPHAEL PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Raphael Pharmaceutical Inc.

Equities

RAPH

US27785B2088

Market Closed - OTC Markets
Other stock markets
 07:00:19 25/06/2024 pm IST 		5-day change 1st Jan Change
1.65 USD +120.00% Intraday chart for Raphael Pharmaceutical Inc. +0.61% +65.00%
15/05 Raphael Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/05 Raphael Pharmaceutical Inc. Begins Proof-Of-Concept Clinical Trial in the United States CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
RAPHAEL PHARMACEUTICAL INC. Stock Raphael Pharmaceutical Inc.
 30.86M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.51B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
LONZA GROUP AG Stock Lonza Group AG
 38.13B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.74B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.03B
  1. Stock Market
  2. Equities
  3. RAPH Stock
  4. Charts Raphael Pharmaceutical Inc.
  5. Sector Chart